Titlebook: Brain Chemistry and Mental Disease; Proceedings of a Sym Beng T. Ho,William M. McIsaac Conference proceedings 1971 Springer Science+Busines

transient-pain

Studies on the Mechanism of Action of 6-Methoxytetrahydro-β-Carboline in Elevating Brain SerotoninGlassman (1969). If resolution of the problem as to the function of these amines lies in the differential elevation of a specific amine, then it would seem desirable to have an agent that would specifically elevate only one brain amine.

晚來的提名

Gullible

細(xì)頸瓶

Multiple Forms of Monoamine Oxidase in Developing Tissues: The Implications for Mental Disorder966; Eberle and Eiduson 1968). More specifically, we believe as others do that a knowledge of how the biosynthesis, tissue levels, and catabolism of these amines are regulated during brain development may lead to a greater understanding of the biochemical and behavioral individuality exhibited by hi

天賦

extrovert

Behavioral, Metabolic, and Enzymatic Studies of a Brain Indoleethylamine N-Methylating Systemlation hypothesis of schizophrenia (Osmond and Smythies 1952) and Axelrod’s exciting and systematic elucidation of various amine-methylating enzymes in the central nervous system (Axelrod 1965), our own particular interests in this field started in 1964 when we were studying the effect of the intrav

河流

Ptsd429

擺動(dòng)

Pharmacological Implications of the Effects of Amphetamine and Its Analogs on the Turnover Rate of TBell (1965), and Kety (1967) have proposed this psychosis as a model for the study of affective disorders and schizophrenia. A better understanding of the biochemical factors involved in the actions elicited by .-amphetamine may increase the practical utility of this model. The picture that has emer

mydriatic

Studies on the Mechanism of Action of 6-Methoxytetrahydro-β-Carboline in Elevating Brain Serotoninion whether low brain serotonin (5-HT) or norepinephrine (NE) is specifically responsible for this abnormal state. The evidence that elevating the level of brain 5-HT alleviates depression was first presented by Coppen, Shaw, and Farrell (1963). They reported that administration of tryptophan to dep